AG
Artal Group Portfolio holdings
AUM
$930M
1-Year Return
3.57%
This Quarter Return
+49.95%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.93B
AUM Growth
+$639M
(+28%)
Cap. Flow
-$173M
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
77.18%
Holding
114
New
14
Increased
16
Reduced
25
Closed
23
Top Buys
| 1 |
argenx
ARGX
|
$44.3M |
| 2 |
Scholar Rock
SRRK
|
$41.4M |
| 3 |
Arrowhead Research
ARWR
|
$31.3M |
| 4 |
Korro Bio
KRRO
|
$20.1M |
| 5 |
Kymera Therapeutics
KYMR
|
$18.5M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$88.2M |
| 2 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$69.4M |
| 3 |
Amicus Therapeutics
FOLD
|
$28.9M |
| 4 |
Cytokinetics
CYTK
|
$25.4M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$24M |
Sector Composition
| 1 | Healthcare | 51.64% |
| 2 | Consumer Discretionary | 47.64% |
| 3 | Technology | 0.45% |
| 4 | Real Estate | 0.14% |
| 5 | Communication Services | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ME
76
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $604K | 0.02% |
33,050
| – | – |
|
77
Eli Lilly
LLY
$666B
| $583K | 0.02% |
+1,000
| New | +$583K |
|
78
Pegasystems
PEGA
$9.21B
| $562K | 0.02% |
23,000
+8,000
| +53% | +$195K |
|
79
Remitly
RELY
$4.06B
| $486K | 0.02% |
+25,000
| New | +$486K |
|
80
Cyclerion Therapeutics
CYCN
$7.66M
| $466K | 0.02% |
138,955
| – | – |
|
81
Confluent
CFLT
$6.4B
| $445K | 0.01% |
+19,000
| New | +$445K |
|
82
MongoDB
MDB
$26.2B
| $409K | 0.01% |
+1,000
| New | +$409K |
|
83
Clearwater Analytics
CWAN
$5.9B
| $401K | 0.01% |
+20,000
| New | +$401K |
|
84
Advanced Micro Devices
AMD
$263B
| $369K | 0.01% |
2,500
-3,500
| -58% | -$517K |
|
85
dLocal
DLO
$3.77B
| $354K | 0.01% |
+20,000
| New | +$354K |
|
86
PayPal
PYPL
$65.4B
| $307K | 0.01% |
5,000
| – | – |
|
87
Xilio Therapeutics
XLO
$37.2M
| $248K | 0.01% |
450,000
| – | – |
|
88
Hippo Holdings
HIPO
$824M
| $219K | 0.01% |
24,000
| – | – |
|
|
CERE
89
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $214K | 0.01% |
5,041
-1,633,817
| -100% | -$69.4M |
|
90
Senti Biosciences
SNTI
$36.1M
| $37K | ﹤0.01% |
5,556
| – | – |
|
91
MiNK Therapeutics
INKT
$62.2M
| $2K | ﹤0.01% |
192
| – | – |
|
|
ADAP
92
Adaptimmune Therapeutics
ADAP
$13.5M
| – | – |
-1,133,775
| Closed | -$884K |
|
93
Alnylam Pharmaceuticals
ALNY
$59.4B
| – | – |
-936
| Closed | -$166K |
|
94
Aurinia Pharmaceuticals
AUPH
$1.65B
| – | – |
-1,000,000
| Closed | -$7.77M |
|
95
Beam Therapeutics
BEAM
$1.88B
| – | – |
-10,975
| Closed | -$264K |
|
96
CrowdStrike
CRWD
$104B
| – | – |
-2,000
| Closed | -$335K |
|
97
Day One Biopharmaceuticals
DAWN
$759M
| – | – |
-500,000
| Closed | -$6.14M |
|
98
Geron
GERN
$880M
| – | – |
-5,565,889
| Closed | -$11.8M |
|
|
IMAB
99
I-MAB
IMAB
$355M
| – | – |
-850,000
| Closed | -$1.12M |
|
100
LAVA Therapeutics
LVTX
$40.8M
| – | – |
-200,000
| Closed | -$294K |
|